Clinical Case Reports (Jun 2023)

Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX‐FP): A case report

  • Francisco José López‐Jaime,
  • Ihosvany Fernández‐Bello,
  • Eva Calavia‐Aranda,
  • Begoña Reina‐Monsó,
  • Adrián Montaño

DOI
https://doi.org/10.1002/ccr3.7439
Journal volume & issue
Vol. 11, no. 6
pp. n/a – n/a

Abstract

Read online

Key Clinical Message In hemophilia patients undergoing cardiac surgery, ROTEM® and Quantra® viscoelastic tests are useful to monitor perioperative hemostatic status and a single dose of rIX‐FP is safe and avoids any hemorrhagic or thrombotic complication. Abstract Cardiac surgery poses a high hemostatic risk in patients with hemophilia. We present the first case of an adult patient with hemophilia B on treatment with albutrepenonacog alfa (rIX‐FP) who underwent surgery for acute coronary syndrome. Treatment with rIX‐FP made it possible to perform the surgery safely.

Keywords